Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8346)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2016 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papp M, Tornai T, Vitalis Z, Tornai I, Tornai D, Dinya T, Sumegi A, Antal-Szalmas P. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. World J Gastroenterol 2016; 22(41): 9172-9185 [PMID: 27895404 DOI: 10.3748/wjg.v22.i41.9172] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v22/i41/9172.htm |
| Number | Citing Articles |
| 1 |
Petra Fischer, Crina Grigoras, Anca Bugariu, Oana Nicoara-Farcau, Horia Stefanescu, Andreea Benea, Adina Hadade, Simona Margarit, Zeno Sparchez, Marcel Tantau, Daniela Ionescu, Bogdan Procopet. Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?. Digestive and Liver Disease 2019; 51(12): 1685 doi: 10.1016/j.dld.2019.05.025
|
| 2 |
Alberto Ferrarese, Mario Plebani, Anna Chiara Frigo, Patrizia Burra, Marco Senzolo. Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease. Journal of Hepatology 2021; 75(1): 232 doi: 10.1016/j.jhep.2021.01.016
|
| 3 |
Senhao Wei, Ziyuan Shen, Yiyuan Yin, Zhukai Cong, Zhaojin Zeng, Xi Zhu. Advances of presepsin in sepsis-associated ARDS. Postgraduate Medical Journal 2024; 100(1182): 209 doi: 10.1093/postmj/qgad132
|
| 4 |
Dmitrii I. Gavrilenko, N.N. Silivontchik. Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers. Clinical Microbiology and Antimicrobial Chemotherapy 2021; 23(2): 147 doi: 10.36488/cmac.2021.2.147-160
|
| 5 |
Alberto Zanetto, Filippo Pelizzaro, Monica Maria Mion, Marco Bucci, Alberto Ferrarese, Paolo Simioni, Daniela Basso, Patrizia Burra, Marco Senzolo. Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0. United European Gastroenterology Journal 2023; 11(9): 815 doi: 10.1002/ueg2.12472
|
| 6 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis. International Journal of Molecular Sciences 2024; 25(4): 1988 doi: 10.3390/ijms25041988
|
| 7 |
Damian Piotrowski, Anna Boroń-Kaczmarska. Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatment. Advances in Medical Sciences 2017; 62(2): 345 doi: 10.1016/j.advms.2016.11.009
|
| 8 |
Fady M. El Gendy, Muhammad S. El-Mekkawy, Nagwan Y. Saleh, Mona Salah El-din Habib, Faten Ezzelarab Younis. Clinical study of Presepsin and Pentraxin3 in critically ill children. Journal of Critical Care 2018; 47: 36 doi: 10.1016/j.jcrc.2018.06.004
|
| 9 |
Razvan Igna, Irina Gîrleanu, Camelia Cojocariu, Laura Huiban, Cristina Muzîca, Ana-Maria Sîngeap, Cătălin Sfarti, Stefan Chiriac, Oana Cristina Petrea, Sebastian Zenovia, Robert Nastasa, Tudor Cuciureanu, Remus Stafie, Ermina Stratina, Adrian Rotaru, Carol Stanciu, Mihaela Blaj, Anca Trifan. The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure. Journal of Clinical Medicine 2022; 11(18): 5410 doi: 10.3390/jcm11185410
|
| 10 |
Jun Shiota, Hitoshi Tagawa, Norihiko Ohura, Hitoshi Kasahara. Presepsin is a potent biomarker for diagnosing skin wound infection in hemodialysis patients compared to white blood cell count, high-sensitivity C-reactive protein, procalcitonin, and soluble CD14. Renal Replacement Therapy 2017; 3(1) doi: 10.1186/s41100-017-0113-z
|
| 11 |
David Tornai, Zsuzsanna Vitalis, Alexa Jonas, Tamas Janka, Ildiko Foldi, Tamas Tornai, Nora Sipeki, Aniko Csillag, Boglarka Balogh, Andrea Sumegi, Roza Foldesi, Maria Papp, Peter Antal-Szalmas. Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality. Clinics and Research in Hepatology and Gastroenterology 2021; 45(5): 101579 doi: 10.1016/j.clinre.2020.11.009
|
| 12 |
Razvan Igna, Irina Gîrleanu, Camelia Cojocariu, Cristina Muzîca, Laura Huiban, Catalin Sfarti, Tudor Cuciureanu, Stefan Chiriac, Ana-Maria Sîngeap, Oana Cristina Petrea, Remus Stafie, Sebastian Zenovia, Robert Năstasă, Ermina Stratina, Adrian Rotaru, Carol Stanciu, Anca Trifan, Mihaela Blaj. The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy. Diagnostics 2022; 12(9): 2077 doi: 10.3390/diagnostics12092077
|
| 13 |
Alberto Ferrarese, Anna Chiara Frigo, Monica Maria Mion, Mario Plebani, Francesco Paolo Russo, Giacomo Germani, Martina Gambato, Umberto Cillo, Annamaria Cattelan, Patrizia Burra, Marco Senzolo. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection. Clinical Chemistry and Laboratory Medicine (CCLM) 2021; 59(4): 775 doi: 10.1515/cclm-2020-1212
|
| 14 |
D. I. Haurylenka, N. N. Silivontchik. TRANSLOCATION OF INTESTINAL MICROFLORA IN CIRRHOSIS. Hepatology and Gastroenterology 2020; 4(2): 143 doi: 10.25298/2616-5546-2020-4-2-143-150
|
| 15 |
Zhongwei Zhang, Ke Ma, Zhongyuan Yang, Qiuyu Cheng, Xue Hu, Meiqi Liu, Yunhui Liu, Tingting Liu, Meng Zhang, Xiaoping Luo, Tao Chen, Qin Ning. Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infectious Diseases and Therapy 2021; 10(3): 1347 doi: 10.1007/s40121-021-00454-2
|